Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

445
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
445
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

14.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

418
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
418

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS.

Journal of neuroinflammation·2026
Same author

A CSF disease-associated macrophage signature defines progressive multiple sclerosis.

Journal of neuroinflammation·2026
Same author

Spontaneous cervical artery dissection is associated with a distinct peripheral immune cell signature.

PloS one·2026
Same author

Interplay Between Thrombospondin-1 and CD36 Modulates Platelet-RBC Interaction in Thrombosis and Abdominal Aneurysm Formation.

Circulation research·2025
Same author

Cytoskeletal disruption-induced calcium dysregulation drives cell death in anti-IgLON5 disease.

Redox biology·2025
Same author

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.

EBioMedicine·2025

Related Experiment Video

Updated: Mar 13, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K

Prothrombin and factor X are elevated in multiple sclerosis patients.

Kerstin Göbel1, Peter Kraft2, Susann Pankratz1

  • 1Department of Neurology, University of Münster, Münster.

Annals of Neurology
|October 25, 2016
PubMed
Summary
This summary is machine-generated.

Coagulation factors like prothrombin and factor X are elevated in relapsing-remitting and secondary progressive multiple sclerosis (MS) patients. These findings suggest coagulation factors may be key mediators in neuroinflammation, offering potential therapeutic targets.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.3K

Related Experiment Videos

Last Updated: Mar 13, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.3K

Area of Science:

  • Neuroimmunology
  • Hematology
  • Coagulation Cascade

Background:

  • Animal models suggest coagulation factors play a role in neuroinflammation beyond hemostasis.
  • The relevance of coagulation factors in human neuroinflammatory diseases remains unclear.

Purpose of the Study:

  • To investigate differences in coagulation factor levels between patients with neuroimmunological disorders and healthy controls.
  • To determine the specific role of coagulation factors in different forms of multiple sclerosis (MS) and neuromyelitis optica (NMO).

Main Methods:

  • Comparative analysis of coagulation factor levels (prothrombin, factor X) in patient cohorts and healthy donors.
  • Stratification of patients based on MS subtype (relapsing-remitting, secondary progressive, primary progressive) and NMO.

Main Results:

  • Significantly higher levels of prothrombin and factor X were observed in patients with relapsing-remitting MS and secondary progressive MS compared to controls.
  • Coagulation factor levels were not significantly different in primary progressive MS and neuromyelitis optica patients compared to healthy donors.

Conclusions:

  • Coagulation factors, specifically prothrombin and factor X, are implicated in the pathophysiology of certain MS subtypes.
  • These findings highlight coagulation factors as potential mediators of neuroinflammation and suggest them as future therapeutic targets for MS.